Read more stories about
Incubators and R&D >>

MATR Sponsor:


MATR Supporters:

Alzheimer's blood test promises detection years before symptoms develop

February 1, 2018View for printing

Amyloid beta deposits, or plaques, in the brain are the most commonly hypothesized causative agent behind Alzheimer's disease. A new breakthrough blood test, developed by an international team of scientists, can reportedly measure the concentration of these amyloid beta concentrations using just a tiny blood sample.

Rich Haridy

https://newatlas.com/alzheimers-blood ... 81-92465361
No reader comments so far. Be the first to comment by clicking the button below.





Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.


E-mail this page to a friend!